Contact us

Laboratory Services

Rapid prototyping and evaluation of potential formulation solutions.

Our laboratory capabilities allow us to rapidly design, develop and evaluate prototype formulation options to speed your progress through development – from preformulation services, to development of preclinical and clinical formulations.

Our laboratory activities include:

  • Physicochemical characterisation and preformulation services
  • Analytical method development and verification
  • Chemical and physical stability studies
  • Preclinical efficacy and safety study formulation development (with a special focus on challenging molecules)
  • First-in-Human formulation prototyping
  • Later phase / commercial formulation prototyping
  • Biorelevant dissolution and development of clinically relevant dissolution tests
  • Enabling formulations and specialist drug delivery technology selection

SEDA’s laboratories can be used as a standalone service which delivers the ‘nuts and bolts’ of data generation. Alternatively, it can be combined with our drug product consulting service to provide the additional advantage of seamless integration of the experimental plan with top end Strategy, Interpretation and Execution which can maximise value build and speed of development.

Our extensive analytical capabilities and suite of in-house analytical instrumentation allow us to support a range of CMC activities extending from early phase method development stability studies and impurity analysis, through to excipient compatibility studies and understanding product formulation and behaviour. The increasing complexity of pharmaceutical compounds encountered today requires a deep understanding of analytical techniques which we apply to solve the most challenging of problems.

With our breadth of specialist knowledge in chemical analysis and imaging (including HPLC & UPLC, Mass Spectrometry (MS), Differential Scanning Calorimetry (DSC), Infrared and Raman Spectroscopy and UV probe dissolution), our experts offer bespoke method development and consultancy in the characterisation and quantitation of pharmaceutical materials, as well as advising on more complex techniques that can be applied to understand preclinical and clinical in vivo behaviour.

Ask our team a question

Expertise:

  • Oral Drug Delivery
  • Complex Medicines
  • Paediatric Product Development
  • CMC Regulatory
  • Analytical Sciences

Marcel de Matas

BSc (Hons) PhD FRSC CChem

Director & Co-Founder

Marcel de Matas

BSc (Hons) PhD FRSC CChem

Director & Co-Founder

View Bio Ask me a question

Marcel has a track record in a range of management and senior scientific positions in industry and academia. Most recently he was a Principal Scientist in Product Design and Innovation at AstraZeneca, where he was responsible for introducing the latest science, new technologies (advanced drug delivery and manufacturing) and product design thinking into the Product Development group.

Marcel has led technical activities, provided project leadership and has managed product development teams responsible for the delivery of drug projects from initial concept design through late stage development, regulatory submission and launch (including advanced drug delivery systems). He has led teams at the drug discovery-development interface, assessing the level of chemistry manufacturing and controls (CMC) technical risk and defining product design strategies in early development. Project experience has covered projects across a range of disease and therapy areas with substantial experience in the oncology field.

Ask me a question

    Expect a reply typically within 48 hours.

    Expertise:

    • Oral Drug Delivery
    • Paediatric Product Development
    • Complex Medicines

    Shanoo Buhdheo

    BSc (Hons)

    Senior Principal Scientist

    Shanoo Buhdheo

    BSc (Hons)

    Senior Principal Scientist

    View Bio Ask me a question

    Shanoo is an experienced pharmaceutical development scientist with many years’ experience in large pharma and the biotech sector. She has a particular interest in biopharmaceutics, development of clinically relevant in vitro tests and the development of products for paediatrics.

    Ask me a question

      Expect a reply typically within 48 hours.